Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics

doi:10.1016/0026-2862(90)90023-K

Microvascular Research

Volume 40, Issue 2, September 1990, Pages 246-263

https://doi.org/10.1016/0026-2862(90)90023-K Get rights and content

Abstract

We have recently developed a general theoretical framework for transvascular exchange and extravascular transport of fluid and macromolecules in tumors. The model was applied to a homogeneous, alymphatic tumor with no extravascular binding. For this simplified system, the interstitial pressure was found to be a major contributing factor to the heterogeneous distribution of macromolecules within solid tumors. A steep pressure gradient was predicted at the periphery of the tumor. Our recent experiments have verified these predicted profiles. The purpose of this investigation was to apply this theoretical framework to the more realistic case of a nonuniformly perfused tumor. The role of lymphatics for macromolecular transport was also studied using the model. The uptake and distribution of IgG and its fragment, Fab, were simulated. The novel result from this work is that necrosis does not reduce the central interstitial pressure in a tumor. Other results showed that (i) macromolecules do not penetrate a necrotic core at early times after injection; (ii) at longer time periods after a bolus injection (days for Fab, months for IgG in a tumor of radius ∼ 1cm) a “reservoir” of material may be formed in the necrotic core; (iii) continuous infusion or repeated injections should maintain a higher interstitial concentration of macromolecules; and (iv) lymphatics, if present in a tumor, would rapidly remove material and result in much lower concentration levels. The model is also used to explain some previous experimental data in the literature on antibody distribution.

References (25)

K. Ballard et al.
Osmotic reflection coefficients of canine subcutaneous adipose tissue endothelium
Microvasc. Res.
(1978)
L.T. Baxter et al.
Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection
Microvasc. Res.
(1989)
J.M. Esteban et al.
Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: Histologic and autoradiographic study of effects on tumors and normal organs
Europ. J. Cancer
(1987)
L.E. Gerlowski et al.
Microvascular permeability of normal and neoplastic tissues
Microvasc. Res.
(1986)
C.A. Wiederhielm
Dynamics of capillary fluid exchange: A nonlinear computer simulation
Mirovasc. Res.
(1979)
K. Aukland et al.
Interstitial fluid volume: Local regulatory mechanisms
Physiol. Rev.
(1981)
L.T. Baxter et al.
Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism
(1990)
Y. Boucher et al.
Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: Implications for therapy
Cancer Res.
(1990)
R.A. Brace et al.
Interaction of transcapillary Starling forces in the isolated dog forelimb
Amer. J. Physiol.
(1977)
M.A. Clauss et al.
Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues
Cancer Res.
(1990)

D.G. Covell et al.

Pharmacokinetics of monoclonal immunoglobulin G1, F(ab′)₂ and Fab′ in mice

Cancer Res.

(1986)

F.E. Curry

Mechanics and thermodynamics of transcapillary exchange

Cited by (314)

Modeling hypoxia-induced radiation resistance and the impact of radiation sources
2024, Computers in Biology and Medicine
Hypoxia contributes significantly to resistance in radiotherapy. Our research rigorously examines the influence of microvascular morphology on radiotherapy outcome, specifically focusing on how microvasculature shapes hypoxia within the microenvironment and affects resistance to a standard treatment regimen ( $30 \times 2 G y_{R B E}$ ). Our computational modeling extends to the effects of different radiation sources. For photons and protons, our analysis establishes a clear correlation between hypoxic volume distribution and treatment effectiveness, with vascular density and regularity playing a crucial role in treatment success. On the contrary, carbon ions exhibit distinct effectiveness, even in areas of intense hypoxia and poor vascularization. This finding points to the potential of carbon-based hadron therapy in overcoming hypoxia-induced resistance to RT. Considering that the spatial scale analyzed in this study is closely aligned with that of imaging data voxels, we also address the implications of these findings in a clinical context envisioning the possibility of detecting subvoxel hypoxia.
Investigating the synergistic effects of immunotherapy and normalization treatment in modulating tumor microenvironment and enhancing treatment efficacy
2024, Journal of Theoretical Biology
We developed a comprehensive mathematical model of cancer immunotherapy that takes into account: i) Immune checkpoint blockers (ICBs) and the interactions between cancer cells and the immune system, ii) characteristics of the tumor microenvironment, such as the tumor hydraulic conductivity, interstitial fluid pressure, and vascular permeability, iii) spatial and temporal variations of the modeled components within the tumor and the surrounding host tissue, iv) the transport of modeled components through the vasculature and between the tumor-host tissue with convection and diffusion, and v) modeling of the tumor draining lymph nodes were the antigen presentation and the development of cytotoxic immune cells take place. Our model successfully reproduced experimental data from various murine tumor types and predicted immune system profiling, which is challenging to achieve experimentally. It showed that combination of ICB therapy and normalization treatments, that aim to improve tumor perfusion, decreases interstitial fluid pressure and increases the concentration of both innate and adaptive immune cells at the tumor center rather than the periphery. Furthermore, using the model, we investigated the impact of modeled components on treatment outcomes. The analysis found that the number of functional vessels inside the tumor region and the ICB dose administered have the largest impact on treatment outcomes.
Spatiotemporal modeling of nano-delivered chemotherapeutics for synergistic microwave ablation cancer therapy
2024, Computer Methods and Programs in Biomedicine
The effectiveness of current microwave ablation (MWA) therapies is limited. Administration of thermosensitive liposomes (TSLs) which release drugs in response to heat has presented a significant potential for enhancing the efficacy of thermal ablation treatment, and the benefits of targeted drug delivery. However, a complete knowledge of the mechanobiological processes underlying the drug release process, especially the intravascular drug release mechanism and its distribution in response to MWA needs to be improved. Multiscale computational-based modeling frameworks, integrating different biophysical phenomena, have recently emerged as promising tools to decipher the mechanobiological events in combo therapies. The present study aims to develop a novel multiscale computational model of TSLs delivery following MWA implantation.
Due to the complex interplay between the heating procedure and the drug concentration maps, a computational model is developed to determine the intravascular release of doxorubicin from TSL, its transvascular transport into the interstitium, transport in the interstitium, and cell uptake. Computational models can estimate the interplays among liposome and drug properties, tumor perfusion, and heating regimen to examine the impact of essential parameters and to optimize a targeted drug delivery platform.
Results indicated that the synergy of TSLs with MWA allows more localized drug delivery with lower side effects. The drug release rate and tumor permeability play crucial roles in the efficacy of TSLs during MWA treatment. The computational model predicted an unencapsulated drug lime around the ablated zone, which can destroy more cancer cells compared to MWA alone by 40%. Administration of TSLs with a high release rate capacity can improve the percentage of killed cancer cells by 24%. Since the heating duration in MWA is less than 15 min, the presented combination therapy showed better performance for highly permeable tumors.
This study highlights the potential of the proposed computational framework to address complex and realistic scenarios in cancer treatment, which can serve as the future research foundation, including advancements in nanomedicine and optimizing the pair of TSL and MWA for both preclinical and clinical studies. The present model could be as a valuable tool for patient-specific calibration of essential parameters.
Intratumoral implantable drug delivery system for targeted localized chemotherapy in breast cancer
2024, Journal of Drug Delivery Science and Technology
Breast cancer is a significant concern for many women, and local chemotherapy has emerged as a promising approach to address this issue. This study focuses on simulating the performance of chemotherapy using Doxorubicin, Cisplatin, Fluorouracil, and Methotrexate loaded in a dual release implantable system within a mathematical framework. The drugs are loaded in the implant as two forms: as free agents and encapsulated in nanoparticles. The results demonstrate that the elimination rate through blood microvessels and the diffusion mechanism play a crucial role in determining the bioavailability and effective penetration depth of the therapeutic agents. Drugs with high elimination rates, such as Doxorubicin, Cisplatin, and Fluorouracil, exhibit improved penetration depth by approximately 4, 3.75, and 2.25 times when encapsulated in small nanoparticles that release their content in the extracellular space. On the other hand, Methotrexate, with its weak removal rate, maintains a sufficient penetration depth and effective concentration level even as a free drug in the extracellular space. Therefore, encapsulating Methotrexate does not significantly impact on tumor penetration. This study emphasizes the potential of the dual implantable system as an effective approach for chemotherapy, particularly when considering the specific chemotherapy drug and the method of loading the therapeutic agent. The system proves to be particularly beneficial in tumors with low microvascular density. These findings provide valuable insights for future research in the development of local drug delivery systems for breast cancer treatment.
Spatiotemporal modeling of radiopharmaceutical transport in solid tumors: Application to <sup>177</sup>Lu-PSMA therapy of prostate cancer
2024, Computer Methods and Programs in Biomedicine
¹⁷⁷Lu-labeled prostate-specific membrane antigen (PSMA) radiopharmaceutical therapy (RPT) represents a pivotal advancement in addressing prostate cancer. However, existing therapies, while promising, remain incompletely understood and optimized. Computational models offer potential insights into RPTs, aiding in clinical drug delivery enhancement. In this study, we investigate the impact of various physiological parameters on the delivery of ¹⁷⁷Lu-PSMA-617 RPT using the convection-diffusion-reaction (CDR) model.
Our investigation encompasses tumor geometry and surrounding tissue, characterized by well-defined boundaries and initial conditions. Utilizing the finite element method, we solve governing equations across a range of parameters: dissociation constant K_D (1, 0.1, 0.01 [nM]), internalization rate (0.01–0.0001 [min⁻¹]), diverse tumor shapes, and variable necrotic zone sizes. This model can provide an accurate analysis of radiopharmaceutical delivery from the injection site to the tumor cell, including drug transport in the vascular, interstitial, and intracellular spaces, and considering important parameters (e.g., drug extravasation from microvessels or to lymphatic vessels, the extracellular matrix, receptors, and intracellular space).
Our findings reveal significant enhancements in tumor-absorbed doses as K_D decreases. This outcome can be attributed to the higher affinity of radiopharmaceuticals for PSMA receptors as K_D diminishes, facilitating a more efficient binding and retention of the therapeutic agent within the tumor microenvironment. Additionally, tumor-absorbed doses for K_D ∼ 1 [nM] show an upward trend with higher internalization rates. This observation can be rationalized by considering that a greater internalization rate would result in a higher proportion of radiopharmaceuticals being taken up by tumor cells after binding to receptors on the cell surface. Notably, tumor shape and necrotic zone size exhibit limited influence on tumor absorbed dose.
The present study employs the CDR model to explore the role of physiological parameters in shaping ¹⁷⁷Lu-PSMA-617 RPT delivery. These findings provide insights for improving prostate cancer therapy by understanding radiopharmaceutical transport dynamics. This computational approach contributes to advancing our understanding of radiopharmaceutical delivery mechanisms and has implications for enhancing treatment efficacy.
Electromechanical convective drug delivery devices for overcoming diffusion barriers
2024, Journal of Controlled Release
Drug delivery systems which rely on diffusion for mass transport, such as hydrogels and nanoparticles, have enhanced drug targeting and extended delivery profiles to improve health outcomes for patients suffering from diseases including cancer and diabetes. However, diffusion-dependent systems often fail to provide >0.01–1% drug bioavailability when transporting macromolecules across poorly permeable physiological tissues such as the skin, solid tumors, the blood-brain barrier, and the gastrointestinal walls. Convection-enabling robotic ingestibles, wearables, and implantables physically interact with tissue walls to improve bioavailability in these settings by multiple orders of magnitude through convective mass transfer, the process of moving drug molecules via bulk fluid flow. In this Review, we compare diffusive and convective drug delivery systems, highlight engineering techniques that enhance the efficacy of convective devices, and provide examples of synergies between the two methods of drug transport.

View all citing articles on Scopus

View full text

Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics

Abstract

Microvasc. Res.

Microvasc. Res.

Europ. J. Cancer

Microvasc. Res.

Mirovasc. Res.

Interstitial fluid volume: Local regulatory mechanisms

Physiol. Rev.

Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism

Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: Implications for therapy

Cancer Res.

Interaction of transcapillary Starling forces in the isolated dog forelimb

Amer. J. Physiol.

Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues

Cancer Res.

Pharmacokinetics of monoclonal immunoglobulin G1, F(ab′)2 and Fab′ in mice

Cancer Res.

Mechanics and thermodynamics of transcapillary exchange

Pharmacokinetics of monoclonal immunoglobulin G1, F(ab′)₂ and Fab′ in mice